Roberto Bini
Roberto Bini is the Director of Cardiology at a medical facility in San Marino, known for his expertise in treating rare cardiac diseases, particularly hypertrophic obstructive cardiomyopathy. Recently, he has been in the news for his involvement in the treatment of patients with this condition using Mavacamten, an innovative medication that has shown promising results in improving patient outcomes and quality of life. Bini emphasizes the significance of this new therapy, which offers a less invasive alternative to traditional treatments and holds potential for extending patients' life expectancy.
Not in the pool (under ¢1).
Recent news mentions
Roberto Bini, the director of the UOC of cardiology, explains the challenges of treating chronic heart disease.
Parte la Settimana del Cuore. Dal 22 al 26 settembre l'ISS organizza incontri formativi e per la prevenzione per i cittadini
San Marino· 2025-09-20
Roberto Bini is the director of the UOC of Cardiology and highlights the underestimation of cardiovascular risk factors in women.
L'ISS lancia il progetto Cardio 40, screening cardiologici per i quarantenni del 2025San Marino· 2025-07-30
Roberto Bini is the Director of Cardiology who discusses the innovative drug Mavacamten and its impact on patients.
nuovo farmaco innovativo con buoni risultatiSan Marino· 2025-07-06